Advanced Breast Cancer: From Biology to Cure
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (31 January 2022) | Viewed by 90049
Special Issue Editor
Interests: breast cancer subtype; HER2; triple negative; luminal tumors; breast cancer therapy; target therapy breast cancer
Special Issue Information
Dear Colleagues,
The rapid evolution of our knowledge of breast cancer biology has led in the last 5 years to the better identification of gene expressions and mutations that arise during treatment, and therefore to the development of new target molecules that impact the outcome of disease and survival. Breast cancer represents the most interesting model of biological information, and this aspect is at the basis of the development of clinical trials that include new methods of biomolecular characterization of the tumor—hence the interest of liquid biopsy in advanced disease and the deeper knowledge of the dynamism of the natural and therapeutic history of this neoplasm. This Special Issue aims to show the thrust of current research for the treatment of advanced breast cancer.
Dr. Alessandra Fabi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- liquid biopsy
- subtype breast cancer
- target therapy
- her2
- luminal tumors
- triple negative tumors
- immunology breast cancer